Researchers at NYU Langone Medical Center and its Perlmutter Cancer Center have uncovered a critical pathway by which pancreatic cancer cells turn off the immune system charged with attacking them. The findings appear in ...
Apr 10, 2017
0
28
A protein known as arginine methyltransferase 1 (PRMT1) may be a potential therapeutic target for pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, and one of the most deadliest with a less ...
Mar 28, 2017
0
1
Researchers have moved an important step closer to understanding why pancreatic cancer is so hard to treat. With a median survival of only 6 months and a 5-year survival rate of about 8%, patients tend to be diagnosed when ...
Feb 23, 2017
0
67
The presence of circulating tumor DNA (ctDNA) isolated from blood samples of patients with pancreatic adenocarcinoma was associated with poor outcomes.
Dec 19, 2016
0
2
Conventional, high-dose chemotherapy treatments can cause the fibroblast cells surrounding tumors to secrete proteins that promote the tumors' recurrence in more aggressive forms, researchers at Taipei Medical University ...
Nov 23, 2016
0
61
Internal conflict between cell types explains why the immune system struggles to recognize and attack pancreatic cancer. Curbing this infighting has the potential to make treatment more effective, according to a study led ...
Aug 25, 2016
0
1
Massachusetts General Hospital (MGH) investigators have discovered the mechanism by which obesity increases inflammation and desmoplasia - an accumulation of connective tissue - in the most common form of pancreatic cancer. ...
Jul 6, 2016
0
15
Researchers have identified a new way to tailor treatments for patients with pancreatic cancer, one of the most deadly forms of cancer. Currently only five per cent of people with pancreatic cancer survive longer than five ...
Jun 14, 2016
0
18
Early diagnosis is key to gaining the upper hand against a wide range of diseases. Now Microsoft researchers are suggesting that records of the topics that people search for on the Internet could one day prove as useful as ...
Jun 8, 2016
0
0
Pancreatic ductal adenocarcinoma, the most common of pancreatic cancers, is extraordinarily lethal, with a 5-year survival rate of just 6 percent. Chemotherapy treatments are poorly effective, in part due to a high degree ...
Jun 6, 2016
0
6
